Cargando…

Amplification of the EGFR and CCND1 Are Coordinated and Play Important Roles in the Progression of Oral Squamous Cell Carcinomas

Oral squamous cell carcinoma (OSCC) is a common cancer in Taiwan and worldwide. To provide some clues for clinical management of OSCC, 72 advanced-stage OSCCs were analyzed using two microarray platforms (26 cases with Affymetrix 500 K and 46 cases with Affymetrix SNP 6.0). Genomic identification of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chien, Huei-Tzu, Cheng, Sou-De, Liao, Chun-Ta, Wang, Hung-Ming, Huang, Shiang-Fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627096/ https://www.ncbi.nlm.nih.gov/pubmed/31159251 http://dx.doi.org/10.3390/cancers11060760

Ejemplares similares

Clinical Implications of FADD Gene Amplification and Protein Overexpression in Taiwanese Oral Cavity Squamous Cell Carcinomas
por: Chien, Huei-Tzu, et al.
Publicado: (2016)

EGFR copy number alterations in primary tumors, metastatic lymph nodes, and recurrent and multiple primary tumors in oral cavity squamous cell carcinoma
por: Huang, Shiang-Fu, et al.
Publicado: (2017)

Epidermal growth factor receptor intron-1 CA repeat polymorphism on protein expression and clinical outcome in Taiwanese oral squamous cell carcinoma
por: Huang, Shiang-Fu, et al.
Publicado: (2017)

Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer
por: Stahl, Phillip, et al.
Publicado: (2015)

Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma
por: Huang, Shiang-Fu, et al.
Publicado: (2012)

Prediction of CCND1 amplification using plasma DNA as a prognostic marker in oesophageal squamous cell carcinoma
por: Takeshita, H, et al.
Publicado: (2010)

Anaplastic multiple myeloma with amplification of the IGH-CCND1 gene fusion
por: Alencar, Rafael Nobrega, et al.
Publicado: (2023)

Preoperative SCC Antigen, CRP Serum Levels, and Lymph Node Density in Oral Squamous Cell Carcinoma
por: Adel, Mohamad, et al.
Publicado: (2016)

Recurrent copy number alterations involving EGFR , CDKN2A , and CCND1 in oral premalignant lesions
por: Jäwert, Fredrik, et al.
Publicado: (2022)

Polygenic Panels Predicting the Susceptibility of Multiple Upper Aerodigestive Tract Cancer in Oral Cancer Patients
por: Chien, Huei-Tzu, et al.
Publicado: (2021)

Analysis of CCND1 protein and circulatory antioxidant enzyme activity association in oral squamous cell carcinoma
por: Sushma, P.S., et al.
Publicado: (2021)

Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.
por: Adélaide, J., et al.
Publicado: (1995)

Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma
por: Hsu, Yin-Ping, et al.
Publicado: (2015)

Amplification and overexpression of CTTN and CCND1 at chromosome 11q13 in Esophagus squamous cell carcinoma (ESCC) of North Eastern Chinese Population
por: Hu, Xiaoxia, et al.
Publicado: (2016)

GATAD1 gene amplification promotes glioma malignancy by directly regulating CCND1 transcription
por: Zhang, Shanshan, et al.
Publicado: (2019)

CCND1 Amplification in Breast Cancer -associations With Proliferation, Histopathological Grade, Molecular Subtype and Prognosis
por: Valla, Marit, et al.
Publicado: (2022)

BAP18 is involved in upregulation of CCND1/2 transcription to promote cell growth in oral squamous cell carcinoma
por: Wang, Xue, et al.
Publicado: (2020)

The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2015)

Clinical Significance in Oral Cavity Squamous Cell Carcinoma of Pathogenic Somatic Mitochondrial Mutations
por: Lai, Chih-Hsiung, et al.
Publicado: (2013)

Oral Squamous Cell Carcinoma in Young Patients Show Higher Rates of EGFR Amplification: Implications for Novel Personalized Therapy
por: Satgunaseelan, Laveniya, et al.
Publicado: (2021)

Polymorphisms of Mismatch Repair Pathway Genes Predict Clinical Outcomes in Oral Squamous Cell Carcinoma Patients Receiving Adjuvant Concurrent Chemoradiotherapy
por: Senghore, Thomas, et al.
Publicado: (2019)

Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target
por: Hung, Chin-Sheng, et al.
Publicado: (2018)

Effect of EGFR on SQSTM1 Expression in Malignancy and Tumor Progression of Oral Squamous Cell Carcinoma
por: Tseng, Yu-Kai, et al.
Publicado: (2021)

Using SCC Antigen and CRP Levels as Prognostic Biomarkers in Recurrent Oral Cavity Squamous Cell Carcinoma
por: Chen, I-How, et al.
Publicado: (2014)

CCND1 Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid Tumors
por: Chen, Yu, et al.
Publicado: (2020)

Cyclin D1 overexpression in Algerian breast cancer women: correlation with CCND1 amplification and clinicopathological parameters
por: Mohammedi, Latifa, et al.
Publicado: (2019)

CCND1 Amplification Profiling Identifies a Subtype of Melanoma Associated With Poor Survival and an Immunosuppressive Tumor Microenvironment
por: Liu, Jun, et al.
Publicado: (2022)

Characteristics and outcome differences in male and female oral cavity cancer patients in Taiwan
por: Lee, Yi-Chieh, et al.
Publicado: (2021)

Oncogene Amplification in Squamous Cell Carcinoma of the Oral Cavity
por: Saranath, Dhananjaya, et al.
Publicado: (1989)

Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer
por: Lundgren, Katja, et al.
Publicado: (2008)

LY2874455 and Abemaciclib Reverse FGF3/4/19/CCND1 Amplification Mediated Gefitinib Resistance in NSCLC
por: Liu, Dongcheng, et al.
Publicado: (2022)

circRNA circ‐CCND1 promotes the proliferation of laryngeal squamous cell carcinoma through elevating CCND1 expression via interacting with HuR and miR‐646
por: Zang, Yanzi, et al.
Publicado: (2020)

Clinical Outcomes of Patients with Oral Cavity Squamous Cell Carcinoma and Retropharyngeal Lymph Node Metastasis Identified by FDG PET/CT
por: Tseng, Jing-Ren, et al.
Publicado: (2013)

Polymorphisms in ERCC5 rs17655 and ERCC1 rs735482 Genes Associated with the Survival of Male Patients with Postoperative Oral Squamous Cell Carcinoma Treated with Adjuvant Concurrent Chemoradiotherapy
por: Senghore, Thomas, et al.
Publicado: (2019)

Inhibition of Tumor Lymphangiogenesis is an Important Part that EGFR-TKIs Play in the Treatment of NSCLC
por: Zhang, Yan, et al.
Publicado: (2020)

An Ultra-Deep Targeted Sequencing Gene Panel Improves the Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma
por: Liao, Chun-Ta, et al.
Publicado: (2016)

The Mitochondrial DNA Northeast Asia CZD Haplogroup Is Associated with Good Disease-Free Survival among Male Oral Squamous Cell Carcinoma Patients
por: Lai, Chih-Hsiung, et al.
Publicado: (2012)

Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma
por: KATO, HIROAKI, et al.
Publicado: (2013)

Prognostic Significance of Cyclins A2, B1, D1, and E1 and CCND1 Numerical Aberrations in Oral Squamous Cell Carcinomas
por: Monteiro, Luís Silva, et al.
Publicado: (2018)

Pre-Treatment Levels of C-Reactive Protein and Squamous Cell Carcinoma Antigen for Predicting the Aggressiveness of Pharyngolaryngeal Carcinoma
por: Chen, Hsuan-Ho, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tn0tj1n83j4e8frq66s6ghblu0